What is the clinical significance and appropriate management of a β‑hydroxybutyrate level of 2.1 mmol/L with normal arterial pH, normal serum glucose, and normal anion gap?

Elevated β-Hydroxybutyrate Without Acidosis: Clinical Significance and Management

A β-hydroxybutyrate (BHB) level of 2.1 mmol/L with normal pH, glucose, and anion gap represents mild ketonemia that does not meet criteria for diabetic ketoacidosis and typically requires investigation of the underlying cause rather than aggressive treatment.

Understanding the Clinical Context

Your patient has mild ketonemia (BHB 2.1 mmol/L) without the metabolic derangements that define DKA. According to established diagnostic criteria, DKA requires:

• Blood glucose >250 mg/dL
• Venous pH <7.3
• Bicarbonate <15 mEq/L
• Moderate to severe ketonemia 1, 2

Since your patient has normal pH, glucose, and anion gap, this is not DKA and should not be treated as such.

Clinical Significance of BHB 2.1 mmol/L

Interpreting the Level

BHB thresholds from the literature:

• <1.0 mmol/L: Generally normal, even with hyperglycemia in stable diabetics 3
• 1.0-3.0 mmol/L: Mild ketonemia requiring investigation
• ≥3.0 mmol/L: Significant ketosis warranting medical review 4, 3
• >3.8 mmol/L (adults): Threshold for DKA diagnosis 4

Your patient's level of 2.1 mmol/L falls in the mild ketonemia range - elevated enough to warrant attention but not severe enough to indicate DKA 3.

What This Represents

This pattern suggests ketone production without significant metabolic acidosis, which can occur in several scenarios:

Most Common Causes:

• Starvation ketosis (fasting, reduced caloric intake, vomiting)
• Alcoholic ketoacidosis (AKA) - though typically presents with some acidosis 2, 5
• Early metabolic stress before full acidosis develops
• SGLT2 inhibitor use (can cause euglycemic ketosis) 6
• Acute illness with poor oral intake in diabetic patients 7

Recommended Management Approach

Immediate Assessment

1. Obtain focused history:

• Recent food/fluid intake and duration of fasting
• Alcohol consumption (recent binge drinking suggests AKA)
• Current medications (especially SGLT2 inhibitors, metformin)
• Symptoms: nausea, vomiting, abdominal pain
• Diabetes type and usual control

2. Check additional labs if not already done:

• Serum bicarbonate and electrolytes (you have these - they're normal)
• Lactate level (to exclude lactic acidosis)
• Renal function (creatinine, BUN)
• Blood glucose (you have this - it's normal)

Treatment Strategy

For BHB 2.1 mmol/L with normal pH/glucose/anion gap:

Primary intervention: Address the underlying cause

• If fasting/poor intake: Provide oral or IV dextrose-containing fluids and encourage carbohydrate intake
• If alcohol-related: IV fluids with dextrose, thiamine supplementation, electrolyte monitoring
• If SGLT2 inhibitor use: Consider temporary discontinuation during acute illness
• If acute illness: Treat the precipitating condition, ensure adequate hydration and nutrition

Do NOT:

• Start insulin infusion (no hyperglycemia or acidosis present)
• Treat as DKA (diagnostic criteria not met) 1, 2
• Use bicarbonate therapy (pH is normal) 1

Monitoring

Recheck BHB in 2-4 hours after initiating treatment:

• Declining trend: Continue current management
• Rising to ≥3.0 mmol/L: Escalate evaluation, consider developing DKA or AKA
• Persistent elevation: Investigate alternative causes more thoroughly

Monitor for development of acidosis:

• Repeat venous pH and bicarbonate if clinical status changes
• Watch for symptoms: abdominal pain, nausea, altered mental status
• Serial anion gap monitoring if BHB continues rising

Important Clinical Pitfalls

Common Mistakes to Avoid

1. Overtreatment: Do not initiate DKA protocols for isolated mild ketonemia. The guidelines are clear that DKA requires the triad of hyperglycemia, acidosis, AND ketonemia 1, 2. Your patient has only one component.

2. Ignoring the finding: While not DKA, BHB 2.1 mmol/L indicates metabolic stress. Research shows that ketonemia in acute illness (even without DKA) correlates with worse glycemic control and may represent an "intermediate state of metabolic dysregulation" 7.

3. Using urine ketones for monitoring: If you're following this patient, continue using blood BHB measurements rather than urine ketones. The nitroprusside method (urine dipsticks) doesn't measure BHB and can be misleading 2, 6.

4. Missing concurrent pathology: Elevated BHB with normal glucose should prompt consideration of:

• Alcoholic ketoacidosis (can present with normal or low glucose) 2, 5
• Metformin-associated lactic acidosis (check lactate if on metformin) 8
• Starvation in the context of acute illness

When to Escalate Care

Admit or observe if:

• BHB rises to ≥3.0 mmol/L 3
• pH drops below 7.3 or bicarbonate falls below 18 mEq/L
• Patient cannot tolerate oral intake
• Underlying acute illness requires hospitalization
• Concern for evolving DKA or AKA

Outpatient management acceptable if:

• Patient can tolerate oral intake
• Reliable follow-up available
• No severe underlying illness
• BHB trending down with initial intervention

Practical Algorithm

For BHB 2.1 mmol/L with normal pH, glucose, and anion gap:

1. Identify cause → History of fasting/vomiting/alcohol/SGLT2i use
2. Provide carbohydrates → Oral if tolerated, IV dextrose if not
3. Hydrate → Oral or IV fluids based on clinical status
4. Recheck BHB in 2-4 hours
   • If declining → Continue management, consider discharge with close follow-up
   • If rising or >3.0 → Escalate monitoring, consider admission
5. Monitor for acidosis development → Serial pH/bicarbonate if clinical concern

This measured approach avoids unnecessary intensive treatment while ensuring appropriate monitoring for potential deterioration.